Ameritas Investment Partners’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
WCA
RHJA
PHP
Ameritas Investment Partners's OPRX Position: Q2 2026 in Review
Ameritas Investment Partners sold out of OptimizeRx (OPRX) in Q2 2026, closing a stake of 1,258 shares — an estimated $7.9K sold.
Ameritas Investment Partners first reported a position in OPRX in Q2 2019 and held it in 28 quarters. The position peaked at $108K in Q3 2021. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.
- Ameritas Investment Partners reported no remaining OptimizeRx position as of Q2 2026 after selling out during the quarter.
- Ameritas Investment Partners sold 1,258 OptimizeRx shares in Q2 2026, an estimated $7.9K.
- Ameritas Investment Partners first reported a position in OptimizeRx in Q2 2019 and held it in 28 quarters.
- Ameritas Investment Partners's OptimizeRx position peaked at $108K in Q3 2021.
- 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.